The EME Programme invites proposals for hypothesis driven research into the underlying mechanisms of action of clinical and public health interventions.
The Health Technology Assessment Programme is accepting stage 1 applications to their commissioned workstream for this evidence synthesis topic: 18/18 Active case finding of coeliac disease
This second opening of the call indicates the EME Programmes continued interest in this area.
Nearly 10,000 people are newly diagnosed each year. Unfortuantely, due to late diagnosis, most patients face a terminal prognosis and life expectancy of a mere 4-6 months. Currently, the 5-year survival rate is only 5%, which is the lowest of all 22 common cancers. However, for those diagnosed in time for surgery, their chance of surviving beyond 5 years increases six-fold.
This is an opportunity for registered healthcare professionals to win €15,000 for a project specifically aimed at improving the nutritional care of patients with a gastroenterological condition.
The Kenneth Rainin Foundation supports research that is potentially transformative to diagnosing, treating and curing Inflammatory Bowel Disease. The Innovator Awards program provides $100,000 grants for one-year research projects, which due to their ground-breaking nature, may not be suitable for funding from more traditional sources.
The NIHR Clinician Scientist Award (NIHR-CS) is a post-doctoral research training fellowship of up to 5 years and is not intended as programme or project grant
Bowel & Cancer Research is seeking proposals of up to £75,000 over 3 years to support PhD students in areas relating to Gastrointestinal diseases, including, but not limited to, bowel cancer, Inflammatory Bowel Diseases and IBS. Awards will be made in November 2018.
The Colorectal Therapies HTC has a strong focus on supporting the development and translation of technology that will address the needs of patients affected by colorectal disease (includes colorectal cancers, IBD, IBS, Crohn’s Disease and Colitis).